Skip to main content
. 2021 Mar 10;9(2):e00723. doi: 10.1002/prp2.723

FIGURE 3.

FIGURE 3

Representative nanoparticulate systems developed for delivery of anti‐VEGF agents.

Note: The figure schematizes nanoparticulate systems loaded with a mAb.